Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Total Current Liabilities (2017 - 2025)

Historic Total Current Liabilities for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $83.1 million.

  • Autolus Therapeutics' Total Current Liabilities rose 5830.89% to $83.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.1 million, marking a year-over-year increase of 5830.89%. This contributed to the annual value of $60.7 million for FY2024, which is 3577.8% up from last year.
  • As of Q3 2025, Autolus Therapeutics' Total Current Liabilities stood at $83.1 million, which was up 5830.89% from $68.2 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Total Current Liabilities ranged from a high of $83.1 million in Q3 2025 and a low of $28.2 million during Q2 2021
  • Moreover, its 5-year median value for Total Current Liabilities was $40.9 million (2024), whereas its average is $44.8 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first plummeted by 1511.27% in 2021, then surged by 6661.21% in 2025.
  • Autolus Therapeutics' Total Current Liabilities (Quarter) stood at $28.6 million in 2021, then soared by 62.4% to $46.4 million in 2022, then decreased by 3.51% to $44.7 million in 2023, then soared by 35.78% to $60.7 million in 2024, then skyrocketed by 36.76% to $83.1 million in 2025.
  • Its Total Current Liabilities was $83.1 million in Q3 2025, compared to $68.2 million in Q2 2025 and $66.6 million in Q1 2025.